Factors associated with second‐line triplet therapy in routine care in relapsed/refractory multiple myeloma

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2710|43|1|45-51

ISSN: 0269-4727

Source: JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.43, Iss.1, 2018-02, pp. : 45-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract